NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drugbenzinga|3/17/2026|depressionShare this article:TwitterFacebookLinkedInEmailCopy Link ONLY AVAILABLE IN PAID PLANS. Originally reported by benzinga. Read moreShare this article:TwitterFacebookLinkedInEmailCopy Link